Patents by Inventor Günther Richter

Günther Richter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for diagnosis of common acute lymphoblastic leukemia by determining the level of gene expression
    Patent number: 8530155
    Abstract: The present invention refers to a method and a kit for diagnosing pediatric common acute leukemia by distinguishing between normal and common acute lymphoblastic leukemic (cALL) cells, wherein the method comprises the step of determining the gene expression of specific genes (markers) referring to this disease and the step of determining whether these genes are up-regulated or down-regulated. The method for determining the gene expression levels can apply hybridization techniques or PCR methods or combinations thereof. The present invention provides new gene markers, which have not been reported in context with cALL and are suitable for the diagnosis of this disease. In addition, the present invention refers to utilizing these targets for the development of targeted therapies employing RNA- and DNA-interference, antibodies, aptamers, anticalins and other small molecules.
    Type: Grant
    Filed: August 17, 2007
    Date of Patent: September 10, 2013
    Assignee: Stefan Burdach
    Inventors: Stefan Burdach, Günther Richter
  • Methods for diagnosis of pediatric common acute lymphoblastic leukemia by determining the level of gene expression
    Publication number: 20100055686
    Abstract: The present invention refers to a method and a kit for diagnosing pediatric common acute leukemia by distinguishing between normal and common acute lymphoblastic leukemic (cALL) cells, wherein the method comprises the step of determining the gene expression of specific genes (markers) referring to this disease and the step of determining whether these genes are up-regulated or down-regulated. The method for determining the gene expression levels can apply hybridization techniques or PCR methods or combinations thereof. The present invention provides new gene markers, which have not been reported in context with cALL and are suitable for the diagnosis of this disease. In addition, the present invention refers to utilizing these targets for the development of targeted therapies employing RNA- and DNA-interference, antibodies, aptamers, anticalins and other small molecules.
    Type: Application
    Filed: August 17, 2007
    Publication date: March 4, 2010
    Applicant: Stefan BURDACH
    Inventors: Stefan Burdach, Günther Richter
  • Enzyme granulates comprising an enzyme and an organic disulfide core
    Patent number: 6204236
    Abstract: New enzyme granulates are described which contain an organic disulfide compound (R—S—S—R), particularly they contain the free amino acid cystine, optionally mixed with the amino acid cysteine. The new enzyme granulates are for us in detergent and cleanser compositions, particularly in dishwasher compositions, and they have properties. For example, insofar as protecting objects made of silver against tarnishing, for example, dishes, cutlery, and other objects to be cleaned.
    Type: Grant
    Filed: March 31, 1999
    Date of Patent: March 20, 2001
    Assignee: Genencor International, Inc.
    Inventors: Hubert A. Herrmann, Rolf Spannagl, Günther Richter